Logo image of BELYS.BR

BELYSSE GROUP NV (BELYS.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:BELYS - BE0974314461 - Common Stock

0.82 EUR
+0.05 (+6.49%)
Last: 12/30/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BELYS. BELYS was compared to 32 industry peers in the Household Durables industry. BELYS has a bad profitability rating. Also its financial health evaluation is rather negative. BELYS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

BELYS had negative earnings in the past year.
BELYS had a positive operating cash flow in the past year.
In the past 5 years BELYS reported 4 times negative net income.
BELYS had a positive operating cash flow in 4 of the past 5 years.
BELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFBELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

With a Return On Assets value of -0.02%, BELYS is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
BELYS has a worse Return On Equity (-0.07%) than 62.50% of its industry peers.
BELYS has a better Return On Invested Capital (6.50%) than 71.88% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BELYS is in line with the industry average of 8.34%.
Industry RankSector Rank
ROA -0.02%
ROE -0.07%
ROIC 6.5%
ROA(3y)-6.24%
ROA(5y)-7.82%
ROE(3y)-25.06%
ROE(5y)-43.08%
ROIC(3y)7.2%
ROIC(5y)6.03%
BELYS.BR Yearly ROA, ROE, ROICBELYS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

BELYS has a better Operating Margin (6.94%) than 68.75% of its industry peers.
In the last couple of years the Operating Margin of BELYS has declined.
BELYS has a better Gross Margin (61.34%) than 84.38% of its industry peers.
BELYS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.94%
PM (TTM) N/A
GM 61.34%
OM growth 3Y-5.22%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
BELYS.BR Yearly Profit, Operating, Gross MarginsBELYS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

BELYS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BELYS remains at a similar level compared to 1 year ago.
The debt/assets ratio for BELYS has been reduced compared to a year ago.
BELYS.BR Yearly Shares OutstandingBELYS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
BELYS.BR Yearly Total Debt VS Total AssetsBELYS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

BELYS has an Altman-Z score of 0.26. This is a bad value and indicates that BELYS is not financially healthy and even has some risk of bankruptcy.
BELYS has a worse Altman-Z score (0.26) than 84.38% of its industry peers.
BELYS has a debt to FCF ratio of 5.00. This is a neutral value as BELYS would need 5.00 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 5.00, BELYS is doing good in the industry, outperforming 71.88% of the companies in the same industry.
A Debt/Equity ratio of 1.79 is on the high side and indicates that BELYS has dependencies on debt financing.
With a Debt to Equity ratio value of 1.79, BELYS is not doing good in the industry: 90.63% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF 5
Altman-Z 0.26
ROIC/WACC0.59
WACC11.06%
BELYS.BR Yearly LT Debt VS Equity VS FCFBELYS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.64 indicates that BELYS should not have too much problems paying its short term obligations.
BELYS's Current ratio of 1.64 is fine compared to the rest of the industry. BELYS outperforms 65.63% of its industry peers.
A Quick Ratio of 0.91 indicates that BELYS may have some problems paying its short term obligations.
The Quick ratio of BELYS (0.91) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 0.91
BELYS.BR Yearly Current Assets VS Current LiabilitesBELYS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

2

3. Growth

3.1 Past

BELYS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -100.00%.
The Revenue has decreased by -6.81% in the past year.
The Revenue has been growing slightly by 0.43% on average over the past years.
EPS 1Y (TTM)-100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-6.81%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.97%

3.2 Future

BELYS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.41% yearly.
BELYS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.36% yearly.
EPS Next Y-70.83%
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%
EPS Next 5YN/A
Revenue Next Year-3.57%
Revenue Next 2Y-0.54%
Revenue Next 3Y0.36%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BELYS.BR Yearly Revenue VS EstimatesBELYS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
BELYS.BR Yearly EPS VS EstimatesBELYS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Forward Earnings ratio of 4.42, the valuation of BELYS can be described as very cheap.
BELYS's Price/Forward Earnings ratio is rather cheap when compared to the industry. BELYS is cheaper than 100.00% of the companies in the same industry.
BELYS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.35.
Industry RankSector Rank
PE N/A
Fwd PE 4.42
BELYS.BR Price Earnings VS Forward Price EarningsBELYS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

BELYS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BELYS is cheaper than 93.75% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BELYS is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.94
EV/EBITDA 3.82
BELYS.BR Per share dataBELYS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%

0

5. Dividend

5.1 Amount

BELYS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BELYSSE GROUP NV

EBR:BELYS (12/30/2025, 7:00:00 PM)

0.82

+0.05 (+6.49%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)10-20 2025-10-20
Earnings (Next)N/A N/A
Inst Owners12.71%
Inst Owner ChangeN/A
Ins Owners5.56%
Ins Owner ChangeN/A
Market Cap29.47M
Revenue(TTM)270.29M
Net Income(TTM)-60.00K
Analysts84.44
Price Target1.63 (98.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.42
P/S 0.11
P/FCF 0.94
P/OCF 0.72
P/B 0.36
P/tB N/A
EV/EBITDA 3.82
EPS(TTM)0
EYN/A
EPS(NY)0.19
Fwd EY22.61%
FCF(TTM)0.87
FCFY106.44%
OCF(TTM)1.14
OCFY139.12%
SpS7.52
BVpS2.25
TBVpS-0.61
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.02%
ROE -0.07%
ROCE 7.92%
ROIC 6.5%
ROICexc 7.68%
ROICexgc 15.79%
OM 6.94%
PM (TTM) N/A
GM 61.34%
FCFM 11.61%
ROA(3y)-6.24%
ROA(5y)-7.82%
ROE(3y)-25.06%
ROE(5y)-43.08%
ROIC(3y)7.2%
ROIC(5y)6.03%
ROICexc(3y)9.18%
ROICexc(5y)7.53%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.77%
ROCE(5y)7.35%
ROICexgc growth 3Y21.45%
ROICexgc growth 5YN/A
ROICexc growth 3Y9.1%
ROICexc growth 5YN/A
OM growth 3Y-5.22%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
F-Score4
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF 5
Debt/EBITDA 3.79
Cap/Depr 48.17%
Cap/Sales 3.56%
Interest Coverage 1.25
Cash Conversion 105.78%
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 0.91
Altman-Z 0.26
F-Score4
WACC11.06%
ROIC/WACC0.59
Cap/Depr(3y)57.9%
Cap/Depr(5y)60.08%
Cap/Sales(3y)3.69%
Cap/Sales(5y)3.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-70.83%
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.81%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.97%
Revenue Next Year-3.57%
Revenue Next 2Y-0.54%
Revenue Next 3Y0.36%
Revenue Next 5YN/A
EBIT growth 1Y-18.41%
EBIT growth 3Y-4.81%
EBIT growth 5YN/A
EBIT Next Year68.18%
EBIT Next 3Y25.03%
EBIT Next 5YN/A
FCF growth 1Y113.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.27%
OCF growth 3YN/A
OCF growth 5YN/A

BELYSSE GROUP NV / BELYS.BR FAQ

What is the fundamental rating for BELYS stock?

ChartMill assigns a fundamental rating of 3 / 10 to BELYS.BR.


What is the valuation status for BELYS stock?

ChartMill assigns a valuation rating of 5 / 10 to BELYSSE GROUP NV (BELYS.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for BELYSSE GROUP NV?

BELYSSE GROUP NV (BELYS.BR) has a profitability rating of 3 / 10.


Can you provide the financial health for BELYS stock?

The financial health rating of BELYSSE GROUP NV (BELYS.BR) is 3 / 10.